Catherine A. Foss

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease

Sangjune Kim, Seung‐Hwan Kwon, Tae‐In Kam et al. · Neuron · 2019 · 1.4K citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

Ying Chen, Mrudula Pullambhatla, Catherine A. Foss et al. · Clinical Cancer Research · 2011 · 399 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer

Shawn Hillier, Kevin Maresca, F.J. Femia et al. · Cancer Research · 2009 · 318 citations · Full text

Medicine, Oncology, Pharmacology +14

Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen:<i>In vivo</i>Imaging in Experimental Models of Prostate Cancer

Catherine A. Foss, Ronnie C. Mease, Hong Fan et al. · Clinical Cancer Research · 2005 · 261 citations · Full text

Medicine, Oncology, Pharmacology +17

Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)

Sangeeta Ray Banerjee, Catherine A. Foss, Mark Castanares et al. · Journal of Medicinal Chemistry · 2008 · 235 citations

Medicine, Oncology, Pharmacology +17